4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-059268
Director bought 139,200 shares at an average $0.22 ($30,916)
- Director sold 6,000 shares at $0.11 ($660)
- Director acquired 4,447,426 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lim Seah H. Director | 2022-10-09 | Purchase | +25,400 | $0.11 | $2,794 | 63,900 | D |
| Lim Seah H. Director | 2023-08-25 | Purchase | +92,100 | $0.27 | $24,867 | 156,000 | D |
| Lim Seah H. Director | 2023-08-30 | Purchase | +20,000 | $0.15 | $3,000 | 176,000 | D |
| Lim Seah H. Director | 2023-09-05 | Purchase | +1,700 | $0.15 | $255 | 177,700 | D |
| Lim Seah H. Director | 2023-12-15 | Sale | −6,000 | $0.11 | $660 | 171,700 | D |
| Lim Seah H. Director | 2023-12-15 | Other acquisition | +4,447,426 | $0.29 | $1,289,754 | 4,619,126 | D |
| Derivatives | |||||||
| Lim Seah H. Director | 2023-12-15 | Other disposition · Promissory Note due 9/16/2025 | −240,000 | 0 | D | ||
| Open-market purchases · 139,200 sh · avg $0.22 · $30,916 | |||||||
| Open-market sales · 6,000 sh · avg $0.11 · $660 | |||||||
Loading xslF345X05/doc4.xml…